Miech Ralph P
Department of Molecular Pharmacology (Box GB3), Warren Alpert Medical School, Brown University, Providence, RI 02912, USA.
Ann Pharmacother. 2007 Dec;41(12):2002-7. doi: 10.1345/aph.1K351. Epub 2007 Oct 23.
To explain a pathopharmacologic mechanism that initiates an increase in hemorrhage following medical abortions with mifepristone.
MEDLINE, PubMed, and Google Scholar databases were searched (1990-July 2007). Key search terms were mifepristone, RU486, medical abortion hemorrhage, bleeding, inflammation, innate immune system, phagocytes, macrocytes, cytokines, interleukins, and nitric oxide.
All articles identified from the data sources were evaluated and all information deemed relevant was included for the information related to the development of the understanding of the pathopharmacology of mifepristone as the initiating cause of increased hemorrhage in medical abortions. Mifepristone's blockade of glucocorticoid receptors, prolonged generation of nitric oxide (NO), and postabortion vasodilatation of uterine vasculature by NO that favors excessive hemorrhage were the criteria used to determine whether information was relevant for inclusion.
Inescapable bacterial contamination of the decidua accompanies spontaneous, surgical, and mifepristone abortions and is routinely overcome by activation of the innate immune system. The combination of the induction of NO synthase (NOS) and local production of NO is one of the key features of the activation of the innate immune system's phagocytes. NO is a potent vasodilator and is associated with menstrual menorrhagia. Glucocorticoids prevent the overproduction of NOS and NO and thereby contribute to the control of hemorrhage in the postabortion phase.
Blockade of the glucocorticoid receptors by mifepristone can result in an excess of NO that is theorized to be the cause of excessive hemorrhage seen in mifepristone abortions.
解释米非司酮药物流产后导致出血增加的病理药理学机制。
检索了MEDLINE、PubMed和谷歌学术数据库(1990年至2007年7月)。关键检索词为米非司酮、RU486、药物流产出血、出血、炎症、固有免疫系统、吞噬细胞、巨噬细胞、细胞因子、白细胞介素和一氧化氮。
对从数据来源中识别出的所有文章进行评估,将所有被认为相关的信息纳入,这些信息与理解米非司酮作为药物流产后出血增加的起始原因的病理药理学发展有关。米非司酮对糖皮质激素受体的阻断、一氧化氮(NO)的长时间生成以及流产后NO引起的子宫血管舒张导致过多出血,这些是用于确定信息是否相关以纳入的标准。
自然流产、手术流产和米非司酮流产后蜕膜均不可避免地受到细菌污染,而固有免疫系统的激活通常可克服这一情况。诱导型一氧化氮合酶(NOS)的诱导和NO的局部产生是固有免疫系统吞噬细胞激活的关键特征之一。NO是一种强效血管舒张剂,与月经过多有关。糖皮质激素可防止NOS和NO的过度产生,从而有助于控制流产后阶段的出血。
米非司酮对糖皮质激素受体的阻断可导致NO过量,理论上这是米非司酮流产中出现过多出血的原因。